“ASSESSMENT OF BLOOD MARKERS AFTER RADIONUCLIDE THERAPY FOR OSTEOGENIC METASTASIS OF KIDNEY AND PROSTATE CANCER ”, Wor.Bul.Pub.Helt., vol. 12, pp. 66–69, Jul. 2022, Accessed: Jul. 22, 2026. Available: https://scholarexpress.net/index.php/wbph/article/view/1135